HBV: Clinical Trials

4 trials for HBV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 21Completed 1

Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
Engerix B, Fendrix - HIV, Communicable Diseases
Phase 2 / Phase 3CompletedSheffield Teaching Hospitals NHS Foundation Trust132015-07-232022-09-29
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)
TAF, TDF, TAF Placebo - HBV, Chronic HBV Infection
Phase 3CompletedGilead Sciences1812015-06-192024-10-15
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)
TAF, TDF, TAF Placebo - HBV, Chronic HBV Infection
Phase 3CompletedGilead Sciences1552015-06-192024-10-02
Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults
E/C/F/TAF - HIV, HBV
Phase 3CompletedGilead Sciences792014-02-252018-11-16

Narrower conditions

Hepatitis (2)  ·  Coinfection (1)  ·  Communicable Diseases (1)  ·  Hepatitis B (1)

Broader conditions

Digestive System Diseases (3)  ·  Liver Diseases (3)  ·  Infections (2)  ·  Blood-Borne Infections (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Hepadnaviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Virus Diseases (1)

Interventions

Tenofovir (2)  ·  tenofovir alafenamide (2)  ·  Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Engerix-B (1)  ·  Fendrix (1)

Sponsors

Gilead Sciences (3)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)

Countries

China (2)  ·  Canada (1)  ·  Japan (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 37771546